Advances, challenges, and future directions in the clinical translation of ECM biomaterials for regenerative medicine applications

[Display omitted] Extracellular Matrix (ECM) scaffolds and biomaterials have been widely used for decades across a variety of diverse clinical applications and have been implanted in millions of patients worldwide. ECM-based biomaterials have been especially successful in soft tissue repair applicat...

Full description

Saved in:
Bibliographic Details
Published in:Advanced drug delivery reviews 2024-08, Vol.211, p.115347, Article 115347
Main Authors: Capella-Monsonís, Héctor, Crum, Raphael J., Hussey, George S., Badylak, Stephen F.
Format: Article
Language:English
Subjects:
Advancing ECM-based therapies
ECM scaffolds
Regenerative medicine
Translational development
Translational science
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] Extracellular Matrix (ECM) scaffolds and biomaterials have been widely used for decades across a variety of diverse clinical applications and have been implanted in millions of patients worldwide. ECM-based biomaterials have been especially successful in soft tissue repair applications but their utility in other clinical applications such as for regeneration of bone or neural tissue is less well understood. The beneficial healing outcome with the use of ECM biomaterials is the result of their biocompatibility, their biophysical properties and their ability to modify cell behavior after injury. As a consequence of successful clinical outcomes, there has been motivation for the development of next-generation formulations of ECM materials ranging from hydrogels, bioinks, powders, to whole organ or tissue scaffolds. The continued development of novel ECM formulations as well as active research interest in these materials ensures a wealth of possibilities for future clinical translation and innovation in regenerative medicine. The clinical translation of next generation formulations ECM scaffolds faces predictable challenges such as manufacturing, manageable regulatory pathways, surgical implantation, and the cost required to address these challenges. The current status of ECM-based biomaterials, including clinical translation, novel formulations and therapies currently under development, and the challenges that limit clinical translation of ECM biomaterials are reviewed herein.
ISSN:0169-409X
1872-8294
1872-8294
DOI:10.1016/j.addr.2024.115347